SP-MHCI-0456-3

HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI

US$507.00

In stock

Description

About HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI

The Hepatitis B Virus (HBV) genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P (P) Peptide (IEDB: 37104) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Protein P (P) Peptide, H-LLAQFTSAI-OH (Uniprot: P03158 aa: 520-527) from JPT is produced under strict quality control and quality management.

HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI - Specifications

  • Peptide sequence: H-LLAQFTSAI-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Hepatitis
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI

References:
Read References with JPT’s Antigen Peptides
HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI has been described in:
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis., J Exp Med, 1995 (PMID: 7532675)
Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection., J Clin Invest, 1995 (PMID: 7544809)
Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells., Leukemia, 2004 (PMID: 14973499)

Documentation

Documentation for HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI

Properties

Properties of HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Hepatitis
Layout: Freeze-dried in glass vial
Organism: Hepatitis B Virus (HBV)
Protein Name: Protein P (P)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to HBV genotype A2 subtype adw (isolate Japan/Nishioka/1983) Protein P 520-527, LLAQFTSAI

Information Values
Sequence: H-LLAQFTSAI-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote